The Micro-Nano Innovation Lab ("mini lab") investigates multidisciplinary approaches to develop new intelligent sensing and robotic strategies in micro/nano scales.

Head of Group

Dr Jang Ah Kim

B414A Bessemer Building
South Kensington Campus

 

 

What we do

The Micro-Nano Innovation Lab ("mini lab") investigates multidisciplinary approaches to develop new intelligent sensing and robotic strategies in micro/nano scales. We study nanotechnology, light-matter interactions, micro-particle dynamics, microscale fluid dynamics, and bioengineering to reach our goal. The research involves the design and manufacture of micro/nano systems for diagnostics (e.g. infections, cancer, neurodegenerative diseases) and microscopic therapies/surgeries (e.g. localised drug delivery, novel minimally invasive procedures).

Why it is important?

Timely identification of illnesses, less intrusive interventions, and precise/personalised treatments in challenging areas within our bodies, like narrow blood vessels, are essential technologies for improved healthcare management. The foundation for empowering these technologies lies in the development of devices capable of sensitively detecting disruptions in microenvironments that impact normal physiology and of precisely addressing these issues via targeted drug delivery, surgery, etc. at the cellular and molecular levels (micro/nano scales). Understanding the pathophysiology and engineering of the designs and functionalities of such devices accordingly is, thus, vital to enhancing current medical technology. Also, this has the potential to drive the development of advanced medical micro-robots with integrated sensing and therapeutic capabilities, offering new opportunities for future advancements in healthcare.

How can it benefit patients?

Early detection of diseases followed by minimally invasive, targeted and personalised therapy can have evident advantages for patients in terms of prognosis, health management, and economic implications. First, it can reduce excessive physical and biochemical alterations to the microenvironments, e.g., scarring after resection, antimicrobial resistance after antibiotics administration, etc., offering a better prognosis with fewer side effects. Micro/nanodevices can also be engineered to be implantable, enabling long-term health monitoring and treatment. Finally, the localised and precise manner of the technology allows efficient planning of the optimal procedures and accurate dosage, resulting in reduced cost.

Meet the team

Citation

BibTex format

@article{Choi:2014:10.1039/c4ra05079g,
author = {Choi, H and Kim, JA and Cho, Y and Hwang, T and Lee, J and Kim, T},
doi = {10.1039/c4ra05079g},
journal = {RSC Advances},
pages = {41922--41926},
title = {Conditioning of graphene surface by CO<inf>2</inf>cluster jet},
url = {http://dx.doi.org/10.1039/c4ra05079g},
volume = {4},
year = {2014}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - © the Partner Organisations 2014. The reduction of resistance and surface roughness obtained by CO2cluster jet were up to 81% and 42.3% compared with pristine graphene. The shifts in Raman spectra also implied chemical doping and "mono-layerization". Thus, CO2cluster jet has the potential for planarization, cleaning and flattening of the graphene. This journal is
AU - Choi,H
AU - Kim,JA
AU - Cho,Y
AU - Hwang,T
AU - Lee,J
AU - Kim,T
DO - 10.1039/c4ra05079g
EP - 41926
PY - 2014///
SP - 41922
TI - Conditioning of graphene surface by CO<inf>2</inf>cluster jet
T2 - RSC Advances
UR - http://dx.doi.org/10.1039/c4ra05079g
VL - 4
ER -

Contact Us

General enquiries

Facility enquiries


The Hamlyn Centre
Bessemer Building
South Kensington Campus
Imperial College
London, SW7 2AZ
Map location